Clinical Trial Update: Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating natriuretic peptides for acutely decompensated heart failure in patients with obstructive airway disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Natriuretic peptides (natriuretic peptides)

Snippet

Sponsor: The Alfred | Conditions: Heart Failure | Phase 3 | Status: TERMINATED